Clinical characterization of NTCP deficiency in paediatric patients : A case‐control study based on SLC10A1 genotyping analysis

Li‐Jing Deng,Wen‐Xian Ouyang,Rui Liu,Mei Deng,Jian‐Wu Qiu,Muhammad‐Rauf Yaqub,Muhammad‐Atif Raza,Wei‐Xia Lin,Li Guo,Hua Li,Feng‐Ping Chen,Ying Ouyang,Yu‐Ge Huang,Yue‐Jun Huang,Xiao‐Ling Long,Xiao‐Ling Huang,Shuang‐Jie Li,Yuan‐Zong Song
DOI: https://doi.org/10.1111/liv.15031
IF: 8.754
2021-08-25
Liver International
Abstract:Na+-taurocholate cotransporting polypeptide deficiency (NTCPD) is a newly described disorder arising from biallelic mutations of the SLC10A1 gene. Due to a lack of compelling evidence from case-control studies, its genotypic and phenotypic features remain open for in-depth investigation. This study aimed to explore the genotypic and clinical phenotypic characteristics of pediatric patients with NTCPD. The SLC10A1 genotypes of all NTCPD patients were confirmed by screening for the prevalent variant c.800C>T and Sanger sequencing when necessary. The clinical presentations and laboratory changes were collected, reviewed, and analyzed, and then qualitatively and quantitatively compared with the relevant controls. A total of 113 pediatric NTCPD patients were diagnosed while c.374dupG and c.682_683delCT were detected as two novel pathogenic mutations. Hypercholanemia was observed in 99.12% of the patients. Indirect hyperbilirubinemia in affected neonates exhibited higher positive rates in comparison to controls. Moreover, transient cholestatic jaundice, elevated liver enzymes, and 25-hydroxyvitamin D (Vit D) deficiency during early infancy were more commonly observed in patients than in controls. All NTCPD patients exhibited favorable clinical outcomes as a result of symptomatic and supportive treatment. The findings enriched the SLC10A1 mutation spectrum and provided comprehensive insights into the phenotypic characteristics of NTCPD. NTCPD should be considered and SLC10A1 gene should be analyzed in patients with above age-dependent clinical features. Furthermore, over investigation and intervention should be avoided in the management of NTCPD patients.
gastroenterology & hepatology
What problem does this paper attempt to address?